Rare diseases
Investigational molecules
Locations
Back to Germany43 clinical trials in Kaiserslautern, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on heart failure prevention and treatment of atherosclerotic cardiovascular disease. Studies evaluate new combination therapies and medications for managing high cholesterol and cardiovascular risks.
Research includes evaluation of novel drug combinations like baxdrostat and dapagliflozin for improved cardiac outcomes.
Comprehensive studies examining treatments for various blood cancers, including chronic lymphocytic leukemia, multiple myeloma, and different types of lymphoma.
Trials investigate novel drug combinations and treatment approaches for both newly diagnosed and relapsed patients.
Studies targeting chronic kidney disease and related conditions, with emphasis on combination therapies for patients with concurrent hypertension and metabolic disorders.
Research focuses on innovative therapeutic approaches to slow disease progression and improve patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
